These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 37977229)

  • 1. Adjunctive glucocorticoid therapy for Pneumocystis jirovecii pneumonia in solid organ transplant recipients: A multicenter cohort, 2015-2020.
    Hosseini-Moghaddam SM; Kothari S; Humar A; Albasata H; Yetmar ZA; Razonable RR; Neofytos D; D'Asaro M; Boggian K; Hirzel C; Khanna N; Manuel O; Mueller NJ; Imlay H; Kabbani D; Tyagi V; Smibert OC; Nasra M; Fontana L; Obeid KM; Apostolopoulou A; Zhang SX; Permpalung N; Alhatimi H; Silverman MS; Guo H; Rogers BA; MacKenzie E; Pisano J; Gioia F; Rapi L; Prasad GVR; Banegas M; Alonso CD; Doss K; Rakita RM; Fishman JA
    Am J Transplant; 2024 Apr; 24(4):653-668. PubMed ID: 37977229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pneumocystis jirovecii pneumonia in solid organ transplant recipients: a descriptive analysis for the Swiss Transplant Cohort.
    Neofytos D; Hirzel C; Boely E; Lecompte T; Khanna N; Mueller NJ; Boggian K; Cusini A; Manuel O; van Delden C;
    Transpl Infect Dis; 2018 Dec; 20(6):e12984. PubMed ID: 30155950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphopenia is associated with late onset Pneumocystis jirovecii pneumonia in solid organ transplantation.
    Werbel WA; Ison MG; Angarone MP; Yang A; Stosor V
    Transpl Infect Dis; 2018 Jun; 20(3):e12876. PubMed ID: 29512868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors and outcomes of Pneumocystis pneumonia in solid organ transplant recipients: Impact of posttransplant lymphoproliferative disorder.
    Yetmar ZA; Duffy D; Smith BH; Vikram HR; Brumble L; Limper AH; Beam E
    Clin Transplant; 2023 Sep; 37(9):e15021. PubMed ID: 37195184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pneumocystis jirovecii and quantitative PCR: Pneumonia or colonization?].
    Gazaignes S; Bergeron A; Menotti J; Desseaux K; Molina JM; De Castro N
    Rev Mal Respir; 2020 Apr; 37(4):299-307. PubMed ID: 32273116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-center outbreak of Pneumocystis jirovecii pneumonia in heart transplant recipients.
    Veronese G; Ammirati E; Moioli MC; Baldan R; Orcese CA; De Rezende G; Veronese S; Masciocco G; Perna E; Travi G; Puoti M; Cipriani M; Tiberi S; Cirillo D; Frigerio M
    Transpl Infect Dis; 2018 Jun; 20(3):e12880. PubMed ID: 29514393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of metagenomic next-generation sequencing in the diagnosis and treatment guidance of Pneumocystis jirovecii pneumonia in renal transplant recipients.
    Zhang F; Chen J; Huang H; Deng X; Zhang W; Zeng M; Liu R; Dai L; Wan Q
    Eur J Clin Microbiol Infect Dis; 2021 Sep; 40(9):1933-1942. PubMed ID: 33880744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Six-month risk of Pneumocystis pneumonia following acute cellular rejection: A case-control study in solid organ transplant recipients.
    Hosseini-Moghaddam SM; Shokoohi M; Singh G; Nagpal AD; Jevnikar AM
    Clin Transplant; 2021 Jul; 35(7):e14322. PubMed ID: 33882151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low incidence of Pneumocystis jirovecii pneumonia in an unprophylaxed liver transplant cohort.
    Sarwar S; Carey B; Hegarty JE; McCormick PA
    Transpl Infect Dis; 2013 Oct; 15(5):510-5. PubMed ID: 23930824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of Pneumocystis jirovecii and Adverse Events Associated With Pneumocystis Prophylaxis in Children Receiving Glucocorticoids.
    Basiaga ML; Ross ME; Gerber JS; Ogdie A
    J Pediatric Infect Dis Soc; 2018 Dec; 7(4):283-289. PubMed ID: 28992298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of
    Cheng YD; Huang CH; Gau SY; Chung NJ; Huang SW; Huang CY; Lee CY
    J Fungi (Basel); 2022 Dec; 9(1):. PubMed ID: 36675844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of early and late Pneumocystis jirovecii Pneumonia in kidney transplant patients: the Korean Organ Transplantation Registry (KOTRY) Study.
    Lee G; Koo TY; Kim HW; Lee DR; Lee DW; Oh J; Kim BS; Kim MS; Yang J;
    Sci Rep; 2022 Jun; 12(1):10682. PubMed ID: 35739203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pneumocystis jirovecii pneumonia in liver transplant recipients: a systematic review.
    Kostakis ID; Sotiropoulos GC; Kouraklis G
    Transplant Proc; 2014 Nov; 46(9):3206-8. PubMed ID: 25420860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The risk factor analysis and treatment experience in pneumocystis jirovecii pneumonia after kidney transplantation.
    Yang P; Zhu X; Liang W; Cai R
    Mycoses; 2021 May; 64(5):495-502. PubMed ID: 33368732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylaxis and treatment of Pneumocystis Jirovecii pneumonia after solid organ transplantation.
    Brakemeier S; Pfau A; Zukunft B; Budde K; Nickel P
    Pharmacol Res; 2018 Aug; 134():61-67. PubMed ID: 29890253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variability of Pneumocystis jirovecii prophylaxis use among pediatric solid organ transplant providers.
    Paulsen G; Michaels MG; Danziger-Isakov L; Dipchand AI; Green M; McCulloch M
    Pediatr Transplant; 2020 Feb; 24(1):e13609. PubMed ID: 31713958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Comprehensive Evaluation of Risk Factors for Pneumocystis jirovecii Pneumonia in Adult Solid Organ Transplant Recipients: A Systematic Review and Meta-analysis.
    Permpalung N; Kittipibul V; Mekraksakit P; Rattanawong P; Nematollahi S; Zhang SX; Steinke SM
    Transplantation; 2021 Oct; 105(10):2291-2306. PubMed ID: 33323766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of caspofungin and low-dose trimethoprim/sulfamethoxazole for the treatment of severe Pneumocystis jirovecii pneumonia in renal transplant recipients.
    Tu GW; Ju MJ; Xu M; Rong RM; He YZ; Xue ZG; Zhu TY; Luo Z
    Nephrology (Carlton); 2013 Nov; 18(11):736-42. PubMed ID: 24571744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pneumocystis jirovecii Pneumonia in Patients with Inflammatory Bowel Disease-a Case Series.
    Vieujean S; Moens A; Hassid D; Rothfuss K; Savarino EV; Vavricka SR; Reenaers C; Jacobsen BA; Allez M; Ferrante M; Rahier JF
    J Crohns Colitis; 2023 Apr; 17(4):472-479. PubMed ID: 36223253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pneumocystis pneumonia in intensive care: clinical spectrum, prophylaxis patterns, antibiotic treatment delay impact, and role of corticosteroids. A French multicentre prospective cohort study.
    Kamel T; Janssen-Langenstein R; Quelven Q; Chelly J; Valette X; Le MP; Bourenne J; Garot D; Fillatre P; Labruyere M; Heming N; Lambiotte F; Lascarrou JB; Lesieur O; Bachoumas K; Ferre A; Maury E; Chalumeau-Lemoine L; Bougon D; Roux D; Guisset O; Coudroy R; Boulain T;
    Intensive Care Med; 2024 Aug; 50(8):1228-1239. PubMed ID: 38829531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.